EUVIMEDEUVIMED entdecken
Crossref

Patient-derived models of UBA5- associated encephalopathy identify defects in neurodevelopment and highlight potential therapeutic avenues

Helen Chen iD, Christy W LaFlamme iD, Yong-Dong Wang iD, Aidan W Blan iD, Nikki Koehler, Renata Mendonca Moraes iD, Athena R Olszewski iD, Edith P Almanza Fuerte iD, Emily S Bonkowski iD, Richa Bajpai, Alfonso Lavado, Shondra M Pruett-Miller iD und 1 weitere

Science Translational Medicine · 07.05.2025 · 17 (797)

DOI: 10.1126/scitranslmed.adn8417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 07.05.2025. Verfasst von Helen Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pediatric Neurological Disease Research, Pediatric Translational Neuroscience Initiative, St. Jude Children's Research Hospital, Memphis, …. Hauptthemen laut MEDLINE: Ubiquitin-Activating Enzymes, Brain Diseases, Models, Biological. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

UBA5 encodes for the E1 enzyme of the UFMylation cascade, which plays an essential role in endoplasmic reticulum (ER) homeostasis. The clinical phenotypes of UBA5 -associated encephalopathy include developmental delays, epilepsy, and intellectual disability. To date, there is no humanized neuronal model to study the cellular and molecular consequences of UBA5 pathogenic variants. We developed and characterized patient-derived cortical organoid cultures from two patients with compound heterozygous variants in UBA5 . Both shared the same missense variant, which encodes a hypomorphic allele (p.A371T), along with a nonsense variant (p.G267* or p.A123fs*4). Single-cell RNA sequencing of 100-day organoids identified defects in GABAergic interneuron development. We demonstrated aberrant neuronal firing and reduction in size of patient-derived organoids. Mechanistically, we showed that ER homeostasis is perturbed along with an exacerbated unfolded protein response pathway in engineered U87-MG cells and patient-derived organoids expressing UBA5 pathogenic variants. We also assessed two potential therapeutic modalities that augmented UBA5 protein abundance to rescue aberrant molecular and cellular phenotypes. We assessed SINEUP, a long noncoding RNA that augments translation efficiency, and CRISPRa, a modified CRISPR-Cas9 approach to augment transcription efficiency to increase UBA5 protein production. Our study provides a humanized model that allows further investigations of UBA5 variants in the brain and highlights promising approaches to alleviate cellular aberrations for this rare, developmental disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Activating EnzymesBrain DiseasesModels, BiologicalHumansOrganoidsEndoplasmic ReticulumMaleFemaleUnfolded Protein ResponseCRISPR-Cas SystemsNeurons

Substanzen

Ubiquitin-Activating EnzymesUBA5 protein, human

Autor:innen und Institutionen

  • Center for Pediatric Neurological Disease Research, Pediatric Translational Neuroscience Initiative, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • St. Jude Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

ORCID-Profile: Helen Chen, Christy W LaFlamme, Yong-Dong Wang, Aidan W Blan, Renata Mendonca Moraes, Athena R Olszewski, Edith P Almanza Fuerte, Emily S Bonkowski, Shondra M Pruett-Miller, Heather C Mefford

Zitieren

APA

Chen, H., LaFlamme, C. W., Wang, Y. D., Blan, A. W., Koehler, N., Mendonca Moraes, R., Olszewski, A. R., Almanza Fuerte, E. P., Bonkowski, E. S., Bajpai, R., Lavado, A., Pruett-Miller, S. M., & Mefford, H. C. (2025). Patient-derived models of UBA5- associated encephalopathy identify defects in neurodevelopment and highlight potential therapeutic avenues. Science Translational Medicine, 17(797). https://doi.org/10.1126/scitranslmed.adn8417

Vancouver

Chen H, LaFlamme CW, Wang YD, Blan AW, Koehler N, Mendonca Moraes R, et al. Patient-derived models of UBA5- associated encephalopathy identify defects in neurodevelopment and highlight potential therapeutic avenues. Science Translational Medicine. 2025;17(797). doi:10.1126/scitranslmed.adn8417

BibTeX
@article{Chen2025,
  author = {Chen, Helen and LaFlamme, Christy W and Wang, Yong-Dong and Blan, Aidan W and Koehler, Nikki and Mendonca Moraes, Renata and Olszewski, Athena R and Almanza Fuerte, Edith P and Bonkowski, Emily S and Bajpai, Richa and Lavado, Alfonso and Pruett-Miller, Shondra M and Mefford, Heather C},
  title = {Patient-derived models of UBA5- associated encephalopathy identify defects in neurodevelopment and highlight potential therapeutic avenues},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {797},
  doi = {10.1126/scitranslmed.adn8417}
}
Kostenlos starten →